Actinium Pharmaceuticals (ATNM) News Today → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free ATNM Stock Alerts $7.03 +0.07 (+1.01%) (As of 04/24/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineOrchest Technologies Elevates Connectivity Landscape with API Business Intelligence Integration and Online Hardware Marketplace Debutfinance.yahoo.com - April 23 at 2:04 PMGlobal Application Programming Interface (API) Security Markets, Trends, Opportunities, and Forecasts, 2028Ffinance.yahoo.com - April 23 at 2:04 PMLEAP Boosts Global Customer Reach with Vonage SIP Trunking API Integrationtmcnet.com - April 22 at 3:24 PMGoogle is shutting down the PaLM API for most usersmsn.com - April 20 at 12:11 AMActinium Says Phase 3 SIERRA Trial Results Of Iomab-B Shows Improving OS For AML Patientsmarkets.businessinsider.com - April 18 at 10:06 AMActinium Highlights Ability of Iomab-B to Overcome High-Risk TP53 Mutation Resulting in Significant Improvement in Overall Survival in Patients with Active Relapsed Refractory AML at the European Bone Marrow Transplant Annual Meetingprnewswire.com - April 18 at 8:00 AMBiotech on a Budget: 7 Stocks Under $10 With Huge Potentialinvestorplace.com - April 15 at 12:54 PMMeta Welcomes Developers to Threads with Open API Documentationmsn.com - April 12 at 10:43 PMOpenAI makes GPT-4 Turbo with Vision generally available through its APIventurebeat.com - April 10 at 11:25 PMMyCompanyWorks launches EntityMachine™, the Innovative Business Entity Formation and Management APItmcnet.com - April 9 at 11:55 PMMeta shares more details on Threads API ahead of June release9to5mac.com - April 9 at 11:55 PMThe API Innovation Center, Apertus Pharmaceuticals Bring API Production of Critical Generic Cancer Drug to U.S. Soilfinance.yahoo.com - April 9 at 10:59 AMGlobal Pharmaceutical CDMO Market Analysis Report 2024-2030: AI-Assisted Drug Active Pharmaceutical Ingredient (API) Synthesis Gaining Attentionfinance.yahoo.com - April 9 at 8:04 AMMEF Pioneers Industry Leading Enterprise Business and Operational LSO API Portfolio for Network Servicestmcnet.com - April 9 at 8:04 AMFY2024 EPS Estimates for Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM) Lifted by Cantor Fitzgeraldmarketbeat.com - April 4 at 9:14 AMNextdoor Launches Ads API Program, Offering Advertisers an Easier Way to Extend Their Campaigns to Nextdoorstockhouse.com - April 4 at 8:45 AMActinium Pharmaceuticals: Strong Buy Rating on Financial Health and Promising Pipelinemarkets.businessinsider.com - April 3 at 8:28 PMFY2024 EPS Estimates for Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM) Decreased by HC Wainwrightmarketbeat.com - April 3 at 6:15 AMHasura Supergraph Brings Unparalleled On-Demand Composability to APIs to Address Data and API Integration Challengestmcnet.com - April 2 at 1:31 PMGlobal High Potency API Contract Manufacturing Market Expects Growth with a CAGR of 8.42% Through 2028finance.yahoo.com - April 2 at 1:31 PMBitwarden Enhances Passwordless.dev Tools with Magic Links API to Streamline Passwordless Authenticationfinance.yahoo.com - April 2 at 11:33 AMActinium Pharmaceuticals, Inc. to Post Q1 2024 Earnings of ($0.42) Per Share, HC Wainwright Forecasts (NYSEAMERICAN:ATNM)marketbeat.com - April 2 at 6:22 AMAnalysts Offer Insights on Healthcare Companies: Actinium Pharmaceuticals (ATNM) and Centessa Pharmaceuticals (CNTA)markets.businessinsider.com - April 1 at 3:14 PMActinium's Phase 3 Trial Results Show Survival Benefit In Acute Myeloid Leukemia Patients; Stock Upmarkets.businessinsider.com - April 1 at 11:22 AMActinium Pharmaceuticals (NYSEAMERICAN:ATNM) Rating Reiterated by HC Wainwrightmarketbeat.com - April 1 at 11:08 AMActinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM) Given Average Rating of "Buy" by Brokeragesmarketbeat.com - April 1 at 10:30 AMActinium Announces Iomab-B Phase 3 SIERRA Trial Results Demonstrating Survival Benefit in High-Risk Relapsed or Refractory Acute Myeloid Leukemia Patients with TP53 Mutations Accepted for Oral Presentation at the 50th European Bone Marrow Transplant Annual Meetingfinance.yahoo.com - April 1 at 8:26 AMActinium Pharmaceuticals' (ATNM) Buy Rating Reaffirmed at HC Wainwrightmarketbeat.com - March 26 at 12:46 PMActinium Announces Clinical Trial to Study Iomab-ACT Targeted Radiotherapy Conditioning with Leading FDA Approved Commercial CAR T-Cell Therapyfinance.yahoo.com - March 26 at 7:25 AMActinium Announces Clinical Trial to Study Iomab-ACT Targeted Radiotherapy Conditioning with Leading FDA Approved Commercial CAR T-Cell Therapyprnewswire.com - March 26 at 7:18 AMAnalysts Offer Insights on Healthcare Companies: Precision BioSciences (DTIL) and Actinium Pharmaceuticals (ATNM)markets.businessinsider.com - March 20 at 6:31 PMActinium spikes as H.C. Wainwright highlights buyout prospects after Fusion dealmsn.com - March 19 at 1:19 PMHC Wainwright Reiterates Buy Rating for Actinium Pharmaceuticals (NYSEAMERICAN:ATNM)marketbeat.com - March 19 at 11:31 AMForge’s API raises bar for player rewards and engagementventurebeat.com - March 16 at 4:11 PMEuroapi: Full-year 2024 guidance suspended due to the temporary pause of API production at the Brindisi site in Italyfinanznachrichten.de - March 15 at 7:59 AMHigh-Risk, High-Reward: Little-Known Biotech Stock ATNM Could Soar on Breakthrough Cancer Treatmentinvestorplace.com - March 15 at 6:15 AMAnalysts Offer Insights on Healthcare Companies: Actinium Pharmaceuticals (ATNM) and P3 Health Partners (PIII)markets.businessinsider.com - March 14 at 4:21 PMKimanis records unhealthy API of 155 amid localised firesmsn.com - March 14 at 1:25 PMForge Launches API for Game Developers to Engage and Reward Players for Their Ongoing Play and Add Battle Pass-like Features to Gamesfinance.yahoo.com - March 14 at 1:25 PMPanTera signs a second agreement for the supply of actinium-225globenewswire.com - March 14 at 2:00 AMUpwind Introduces API Security Solution With Real-Time Insights at the Runtime Levelfinance.yahoo.com - March 13 at 1:09 PMMikMak Launches Latest Platform Enhancements Including Headless Commerce API and Custom Analyticstmcnet.com - March 13 at 1:09 PMUS oil inventories in surprise slump last week: APImsn.com - March 12 at 6:29 PMDeepgram Launches Aura, a Text-to-Speech API for Real-Time, Conversational Voice AI Agentstmcnet.com - March 12 at 12:04 PMGlobal API Management Market Size is Estimated to Reach USD 7.02 billion by 2030, Growing at a CAGR of 22.15%: Straits Researchfinance.yahoo.com - March 12 at 10:23 AMPTV Logistics Announces Launch of PTV Developer OptiFlow API to Help Customers Reduce Costs and Emissionsfinance.yahoo.com - March 12 at 8:28 AMActinium Pharmaceuticals (NYSEAMERICAN:ATNM) Rating Increased to Hold at StockNews.commarketbeat.com - March 11 at 11:22 PMBuy Rating Affirmed: Strategic Advances and Clinical Potential Bolster Actinium Pharmaceuticals’ Outlookmarkets.businessinsider.com - March 11 at 8:48 PMAfter losing access to Twitter's API, Block Party pivots to privacyyahoo.com - March 11 at 4:02 PMGoogle Marketing Platform launches new API with enhanced capabilitiesmsn.com - March 11 at 1:23 PM Get Actinium Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ATNM and its competitors with MarketBeat's FREE daily newsletter. Email Address The #1 Biotech Stock to Have on Your Radar in 2024… (Ad)Revenues exploding, a $18.70 price target, and highly lucrative addressable markets make this one you cannot ignore! Learn more about why Zack’s has a BULLISH nearly $19 price target on BSEM right now! ATNM Media Mentions By Week ATNM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ATNM News Sentiment▼0.550.43▲Average Medical News Sentiment ATNM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ATNM Articles This Week▼62▲ATNM Articles Average Week Get Actinium Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ATNM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ALDX News Today CDT News Today OVID News Today VNDA News Today HOWL News Today GTHX News Today ABEO News Today ACIU News Today GALT News Today DSGN News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:ATNM) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersFed launches fourth dollar overhaulStansberry ResearchThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Actinium Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
